EXPDBuy
Expeditors International
Price (1y)
Fair price check
5 different valuation methods each estimate what EXPD should be worth, then we compare to today's price.
- P/E multiplesFairthinks it's fairly priced — estimates $178.36, about 15% above today
- EV/EBITDAFairthinks it's fairly priced — estimates $158.10, about 2% above today
- P/B multiplesOvervaluedthinks it's expensive — estimates $115.03, about 26% below today
- Residual IncomeOvervaluedthinks it's expensive — estimates $46.83, about 70% below today
- Graham (defensive)Overvaluedthinks it's expensive — estimates $46.64, about 70% below today
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
| Method | Value |
|---|---|
| Graham (defensive) | $46.64 |
| P/E multiples(vs sector peers) | $178.36 |
| P/B multiples(vs sector peers) | $115.03 |
| EV/EBITDA(vs sector peers) | $158.10 |
| Residual Income | $46.83 |
| DCF (2-stage) | skipped |
Median of all applicable methods (current price $155.45). Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Pillar breakdown
8 dimensions, each scored 0–100 against the universe
- QualityProfit margins & asset efficiency74Strong
- ValuePrice vs fundamentals64Decent
- GrowthRevenue & earnings trajectory35Weak
- MomentumRecent price strength62Decent
- HealthBalance sheet & solvency68Decent
- ProfitabilityROE, ROA, ROIC56Decent
- TechnicalTrend & volatility signals60Decent
- RiskVolatility & drawdown profile61Decent
Pillars not shown: Sentiment, ML (Phase 5+).
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $20.33B |
| Revenue (TTM) | $11.19B |
| Net income (TTM) | $837.99M |
| Operating cash flow (TTM) | $973.11M |
| CapEx (TTM) | $52.56M |
| Free cash flow (TTM)CFO − CapEx | $920.55M |
| Total assets | $4.78B |
| Total liabilities | N/A |
| Stockholders' equity | $2.28B |
| Cash & equivalents | $1.32B |
| Shares outstanding | 130.79M |
| EPS (basic) | $1.72 |
| EPS (diluted) | $1.71 |
| P/E ratio (TTM) | 24.26 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-05-06
- Latest period end
- 2026-05-01
- Filing lag
- 10 days
- Missing metrics
- 9(total_liabilities, gross_profit, cost_of_revenue, research_and_development, sga_expense, interest_expense, inventory, long_term_debt, short_term_debt)
Phase 3c — composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars land in Phases 5-6; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.